Linical Co., Ltd. (2183.T)
JPY 330.0
(0.92%)
JPY 330.0
(0.92%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3 Billion JPY | -15.25% |
| 2022 | 3.54 Billion JPY | -13.7% |
| 2021 | 4.1 Billion JPY | -12.53% |
| 2020 | 4.69 Billion JPY | 0.93% |
| 2019 | 4.64 Billion JPY | -1.57% |
| 2018 | 4.72 Billion JPY | 406.03% |
| 2017 | 933.44 Million JPY | -13.04% |
| 2016 | 1.07 Billion JPY | -11.54% |
| 2015 | 1.21 Billion JPY | -29.49% |
| 2014 | 1.72 Billion JPY | 332.92% |
| 2013 | 397.5 Million JPY | -9.87% |
| 2012 | 441.02 Million JPY | -7.1% |
| 2011 | 474.75 Million JPY | -6.43% |
| 2010 | 507.37 Million JPY | 1651.81% |
| 2009 | 28.96 Million JPY | -26.74% |
| 2008 | 39.53 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.45 Billion JPY | -8.36% |
| 2023 Q2 | 3.2 Billion JPY | -5.72% |
| 2023 FY | 3 Billion JPY | -15.25% |
| 2023 Q4 | 3 Billion JPY | -0.99% |
| 2023 Q3 | 3.03 Billion JPY | -5.53% |
| 2023 Q1 | 3.4 Billion JPY | -3.89% |
| 2022 Q1 | 3.99 Billion JPY | -2.65% |
| 2022 Q2 | 3.83 Billion JPY | -4.03% |
| 2022 Q3 | 3.68 Billion JPY | -4.02% |
| 2022 Q4 | 3.54 Billion JPY | -3.76% |
| 2022 FY | 3.54 Billion JPY | -13.7% |
| 2021 Q2 | 4.19 Billion JPY | -7.42% |
| 2021 Q1 | 4.53 Billion JPY | -3.42% |
| 2021 Q3 | 4.23 Billion JPY | 1.01% |
| 2021 Q4 | 4.1 Billion JPY | -3.15% |
| 2021 FY | 4.1 Billion JPY | -12.53% |
| 2020 FY | 4.69 Billion JPY | 0.93% |
| 2020 Q2 | 4.9 Billion JPY | -10.03% |
| 2020 Q1 | 5.44 Billion JPY | 17.16% |
| 2020 Q3 | 5.24 Billion JPY | 7.03% |
| 2020 Q4 | 4.69 Billion JPY | -10.54% |
| 2019 FY | 4.64 Billion JPY | -1.57% |
| 2019 Q4 | 4.64 Billion JPY | -7.53% |
| 2019 Q1 | 5.22 Billion JPY | 10.55% |
| 2019 Q3 | 5.02 Billion JPY | 2.97% |
| 2019 Q2 | 4.88 Billion JPY | -6.48% |
| 2018 Q1 | 5.04 Billion JPY | 440.84% |
| 2018 FY | 4.72 Billion JPY | 406.03% |
| 2018 Q4 | 4.72 Billion JPY | -5.69% |
| 2018 Q3 | 5 Billion JPY | 2.98% |
| 2018 Q2 | 4.86 Billion JPY | -3.66% |
| 2017 Q4 | 933.44 Million JPY | -21.79% |
| 2017 Q1 | 1.26 Billion JPY | 17.7% |
| 2017 FY | 933.44 Million JPY | -13.04% |
| 2017 Q2 | 1 Billion JPY | -20.58% |
| 2017 Q3 | 1.19 Billion JPY | 18.94% |
| 2016 Q4 | 1.07 Billion JPY | -23.36% |
| 2016 Q1 | 1.65 Billion JPY | 36.49% |
| 2016 FY | 1.07 Billion JPY | -11.54% |
| 2016 Q2 | 1.14 Billion JPY | -30.96% |
| 2016 Q3 | 1.4 Billion JPY | 22.5% |
| 2015 Q2 | 1.63 Billion JPY | -16.36% |
| 2015 Q4 | 1.21 Billion JPY | -11.33% |
| 2015 Q1 | 1.95 Billion JPY | 13.66% |
| 2015 FY | 1.21 Billion JPY | -29.49% |
| 2015 Q3 | 1.36 Billion JPY | -16.35% |
| 2014 FY | 1.72 Billion JPY | 332.92% |
| 2014 Q1 | 450 Million JPY | 13.21% |
| 2014 Q4 | 1.72 Billion JPY | -7.33% |
| 2014 Q3 | 1.85 Billion JPY | 385.5% |
| 2014 Q2 | 382.5 Million JPY | -15.0% |
| 2013 Q3 | 564.1 Million JPY | 31.48% |
| 2013 Q4 | 397.5 Million JPY | -29.53% |
| 2013 FY | 397.5 Million JPY | -9.87% |
| 2013 Q1 | 648.12 Million JPY | 46.96% |
| 2013 Q2 | 429.02 Million JPY | -33.8% |
| 2012 Q1 | 694.23 Million JPY | 46.23% |
| 2012 Q2 | 459.36 Million JPY | -33.83% |
| 2012 Q3 | 570.07 Million JPY | 24.1% |
| 2012 Q4 | 441.02 Million JPY | -22.64% |
| 2012 FY | 441.02 Million JPY | -7.1% |
| 2011 Q1 | 579.42 Million JPY | 14.2% |
| 2011 FY | 474.75 Million JPY | -6.43% |
| 2011 Q2 | 492.32 Million JPY | -15.03% |
| 2011 Q3 | 531.91 Million JPY | 8.04% |
| 2011 Q4 | 474.75 Million JPY | -10.75% |
| 2010 Q3 | 593.12 Million JPY | 1030.3% |
| 2010 Q4 | 507.37 Million JPY | -14.46% |
| 2010 FY | 507.37 Million JPY | 1651.81% |
| 2010 Q2 | 52.47 Million JPY | 0.0% |
| 2009 Q1 | 164.38 Million JPY | 315.79% |
| 2009 FY | 28.96 Million JPY | -26.74% |
| 2009 Q4 | 28.96 Million JPY | -73.11% |
| 2009 Q3 | 107.69 Million JPY | 25.15% |
| 2009 Q2 | 86.05 Million JPY | -47.65% |
| 2008 Q4 | 39.53 Million JPY | 0.0% |
| 2008 FY | 39.53 Million JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | -21.55% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 18.855% |
| Trans Genic Inc. | 2.25 Billion JPY | -33.001% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -130021.5% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | -21.448% |
| AnGes, Inc. | 362.67 Million JPY | -727.712% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -2709.482% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 95.942% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -1172.09% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -170.706% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -1540.644% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -239.151% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -716.36% |
| Chiome Bioscience Inc. | 291 Million JPY | -931.582% |
| Kidswell Bio Corporation | 2.57 Billion JPY | -16.579% |
| PeptiDream Inc. | 22.79 Billion JPY | 86.834% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -852.471% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -351.414% |
| Healios K.K. | 4.53 Billion JPY | 33.762% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -2568.358% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -2001.393% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -2977.549% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -221.644% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -210.114% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -314.667% |
| StemCell Institute Inc. | 8.78 Million JPY | -34074.67% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -1884.729% |